121 related articles for article (PubMed ID: 9776356)
1. Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes.
Batty KT; Ilett KF; Edwards G; Powell SM; Maggs JL; Park BK; Davis TM
Br J Pharmacol; 1998 Sep; 125(1):159-67. PubMed ID: 9776356
[TBL] [Abstract][Full Text] [Related]
2. Effects of Plasmodium berghei infection on arteether metabolism and disposition.
Leo KU; Grace JM; Li Q; Peggins J; Mitchell AL; Aguilar T; Brewer TG
Pharmacology; 1997 May; 54(5):276-84. PubMed ID: 9380774
[TBL] [Abstract][Full Text] [Related]
3. Relative bioavailability of artesunate and dihydroartemisinin: investigations in the isolated perfused rat liver and in healthy Caucasian volunteers.
Batty KT; Iletr KE; Powell SM; Martin J; Davis TM
Am J Trop Med Hyg; 2002 Feb; 66(2):130-6. PubMed ID: 12135281
[TBL] [Abstract][Full Text] [Related]
4. Toxicokinetics and hydrolysis of artelinate and artesunate in malaria-infected rats.
Li Q; Xie LH; Si Y; Wong E; Upadhyay R; Yanez D; Weina PJ
Int J Toxicol; 2005; 24(4):241-50. PubMed ID: 16126618
[TBL] [Abstract][Full Text] [Related]
5. Malaria infection impairs glucuronidation and biliary excretion by the isolated perfused rat liver.
Murdoch RT; Ghabrial H; Mihaly GW; Morgan DJ; Smallwood RA
Xenobiotica; 1991 Dec; 21(12):1571-82. PubMed ID: 1785204
[TBL] [Abstract][Full Text] [Related]
6. Effect of malaria on phenol conjugation pathways in perfused rat liver.
Murdoch RT; Ghabrial H; Smallwood RA; Morgan DJ
Biochem Pharmacol; 1992 Mar; 43(6):1229-34. PubMed ID: 1562275
[TBL] [Abstract][Full Text] [Related]
7. Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria.
Binh TQ; Ilett KF; Batty KT; Davis TM; Hung NC; Powell SM; Thu LT; Thien HV; Phuöng HL; Phuong VD
Br J Clin Pharmacol; 2001 Jun; 51(6):541-6. PubMed ID: 11422013
[TBL] [Abstract][Full Text] [Related]
8. Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases.
Ilett KF; Ethell BT; Maggs JL; Davis TM; Batty KT; Burchell B; Binh TQ; Thu le TA; Hung NC; Pirmohamed M; Park BK; Edwards G
Drug Metab Dispos; 2002 Sep; 30(9):1005-12. PubMed ID: 12167566
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria.
Ilett KF; Batty KT; Powell SM; Binh TQ; Thu le TA; Phuong HL; Hung NC; Davis TM
Br J Clin Pharmacol; 2002 Jan; 53(1):23-30. PubMed ID: 11849191
[TBL] [Abstract][Full Text] [Related]
10. The effect of malaria infection on primaquine elimination in the isolated perfused rat liver.
Mihaly GW; Date NM; Ireton HJ; Smallwood RA
Biochem Pharmacol; 1987 Jan; 36(2):225-8. PubMed ID: 3814168
[TBL] [Abstract][Full Text] [Related]
11. Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
Sallustio BC; Fairchild BA; Shanahan K; Evans AM; Nation RL
Drug Metab Dispos; 1996 Sep; 24(9):984-9. PubMed ID: 8886608
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
Simpson JA; Agbenyega T; Barnes KI; Di Perri G; Folb P; Gomes M; Krishna S; Krudsood S; Looareesuwan S; Mansor S; McIlleron H; Miller R; Molyneux M; Mwenechanya J; Navaratnam V; Nosten F; Olliaro P; Pang L; Ribeiro I; Tembo M; van Vugt M; Ward S; Weerasuriya K; Win K; White NJ
PLoS Med; 2006 Nov; 3(11):e444. PubMed ID: 17132053
[TBL] [Abstract][Full Text] [Related]
13. The effect of malaria infection on 3'-azido-3'-deoxythymidine and paracetamol glucuronidation in rat liver microsomes.
Ismail S; Back DJ; Edwards G
Biochem Pharmacol; 1992 Nov; 44(9):1879-82. PubMed ID: 1449539
[TBL] [Abstract][Full Text] [Related]
14. Effect of malaria infection on the pharmacokinetics of paracetamol in rat.
Ismail S; Kokwaro GO; Back DJ; Edwards G
Xenobiotica; 1994 Jun; 24(6):527-33. PubMed ID: 7975718
[TBL] [Abstract][Full Text] [Related]
15. A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria.
Batty KT; Le AT; Ilett KF; Nguyen PT; Powell SM; Nguyen CH; Truong XM; Vuong VC; Huynh VT; Tran QB; Nguyen VM; Davis TM
Am J Trop Med Hyg; 1998 Nov; 59(5):823-7. PubMed ID: 9840605
[TBL] [Abstract][Full Text] [Related]
16. The rat biliary metabolites of dihydroartemisinin, an antimalarial endoperoxide.
Maggs JL; Madden S; Bishop LP; O'Neill PM; Park BK
Drug Metab Dispos; 1997 Oct; 25(10):1200-4. PubMed ID: 9321524
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of dihydroartemisinin in a murine malaria model.
Batty KT; Gibbons PL; Davis TM; Ilett KF
Am J Trop Med Hyg; 2008 Apr; 78(4):641-2. PubMed ID: 18385362
[TBL] [Abstract][Full Text] [Related]
18. In vitro evidence for auto-induction of artemisinin metabolism in the rat.
Gupta S; Svensson US; Ashton M
Eur J Drug Metab Pharmacokinet; 2001; 26(3):173-8. PubMed ID: 11695717
[TBL] [Abstract][Full Text] [Related]
19. (S)-4'-hydroxypropranolol causes product inhibition and dose-dependent bioavailability of propranolol enantiomers in the isolated perfused rat liver and in rat liver microsomes.
Nand RA; Ghabrial H; Smallwood RA; Morgan DJ
Xenobiotica; 1996 Dec; 26(12):1249-61. PubMed ID: 9004455
[TBL] [Abstract][Full Text] [Related]
20. Verapamil hepatic clearance in four preclinical rat models: towards activity-based scaling.
Nicolaï J; De Bruyn T; Van Veldhoven PP; Keemink J; Augustijns P; Annaert P
Biopharm Drug Dispos; 2015 Oct; 36(7):462-80. PubMed ID: 25963583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
